Development and characterization of glutathione-conjugated albumin nanoparticles for improved brain delivery of hydrophilic fluorescent marker

References

• Acharya S, Sahoo S.K. (2011). PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev 63:170–83
   PubMed Web of Science ®Google Scholar
• Bagger MA, Bechgaard E. (2004). The potential of nasal application for delivery to the central brain -- a microdialysis study of fluorescein in rats. Eur J Pharm Sci 21:235–42
   PubMed Web of Science ®Google Scholar
• Banks WA. (2012). Drug delivery to the brain in Alzheimer's disease: consideration of the blood–brain barrier. Adv Drug Deliv Rev 64:629–39
   PubMed Web of Science ®Google Scholar
• Benarroch EE. (2010). Glutamate transporters: diversity, function, and involvement in neurologic disease. Neurology 74:259–64
   PubMed Web of Science ®Google Scholar
• Benarroch EE. (2012). Blood–brain barrier. Neurology 78:1268–76
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnurch A, Kast CE, Guggi D. (2003). Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systems. J Control Release 93:95–103
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnurch A, Steininger S. (2000). Synthesis and characterisation of mucoadhesive thiolated polymers. Int J Pharm 194:239–47
   PubMed Web of Science ®Google Scholar
• Bowman GL, Kaye JA, Moore M, et al. (2007). Blood--brain barrier impairment in Alzheimer disease: stability and functional significance. Neurology 68:1809–14
   PubMed Web of Science ®Google Scholar
• Catuogno S, Esposito CL, Quintavalle G, et al. (2012). Nucleic Acids in human glioma treatment: innovative approaches and recent results. J Signal Transduct 11:1--11
   Google Scholar
• Chakraborty SP, Das S, Chattopadhyay S, et al. (2012). Staphylococcus aureus infection induced redox signaling and DNA fragmentation in T-lymphocytes: possible ameliorative role of nanoconjugated vancomycin. Toxicol Mech Methods 22:193–204
   PubMed Web of Science ®Google Scholar
• Chin TY, Chueh SH, Tao PL. (2006). S-Nitrosoglutathione and glutathione act as NMDA receptor agonists in cultured hippocampal neurons. Acta Pharmacol Sin 27:853–60
   PubMed Web of Science ®Google Scholar
• Dringen R, Hirrlinger J. (2003). Glutathione pathways in the brain. Biol Chem 384:505–16
   PubMed Web of Science ®Google Scholar
• Elsabahy M, Wooley KL. (2012). Design of polymeric nanoparticles for biomedical delivery applications. Chem Soc Rev 41:2545–61
   PubMed Web of Science ®Google Scholar
• Fluorescein Novartis [Online]. Available from: http://www.betterhealth.vic.gov.au/bhcv2/bhcmed.nsf/pages/nvcfluin/$File/nvcfluin.pdf [last accessed 8 Jan 2013]
   Google Scholar
• Freytag T, Dashevsky A, Tillman L, et al. (2000). Improvement of the encapsulation efficiency of oligonucleotide-containing biodegradable microspheres. J Control Release 69:197–207
   PubMed Web of Science ®Google Scholar
• Gaillard PJ, Appeldoorn CC, Rip J, et al. (2012). Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation. J Control Release 164:364–9
   PubMed Web of Science ®Google Scholar
• Garberg P, Ball M, Borg N, et al. (2005). In vitro models for the blood--brain barrier. Toxicol In Vitro 19:299–334
   PubMed Web of Science ®Google Scholar
• Geldenhuys W, Mbimba T, Bui T, et al. (2011). Brain-targeted delivery of paclitaxel using glutathione-coated nanoparticles for brain cancers. J Drug Target 19:837–45
   PubMed Web of Science ®Google Scholar
• Govender T, Stolnik S, Garnett MC, et al. (1999). PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J Control Release 57:171–85
   PubMed Web of Science ®Google Scholar
• Guo P, Weinstein AM, Weinbaum S. (2003). A dual-pathway ultrastructural model for the tight junction of rat proximal tubule epithelium. Am J Physiol Renal Physiol 285:F241–57
   PubMed Web of Science ®Google Scholar
• He C, Hu Y, Yin L, et al. (2010). Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 31:3657–66
   PubMed Web of Science ®Google Scholar
• Jain A, Chourasia MK, Soni V, et al. (2006). Brain-specific delivery of rifampin from lactyl stearate-coupled liposomes via monocarboxylic acid transporters. Adv Drug Deliv Rev 4:43–9
   Google Scholar
• Jayant RD, Srivastava R. (2007). Dexamethasone release from uniform sized nanoengineered alginate microspheres. J Biomed Nanotechnol 3:245–53
   Web of Science ®Google Scholar
• Jiao H, Wang Z, Liu Y, et al. (2011). Specific role of tight junction proteins claudin-5, occludin, and ZO-1 of the blood--brain barrier in a focal cerebral ischemic insult. J Mol Neurosci 44:130–9
   PubMed Web of Science ®Google Scholar
• Jin X, Xu Y, Shen J, et al. (2011). Chitosan–glutathione conjugate-coated poly(butyl cyanoacrylate) nanoparticles: promising carriers for oral thymopentin delivery. Carbohydrate Polymers 86:51–7
   Web of Science ®Google Scholar
• Jun JY, Nguyen HH, Paik S-Y-R, et al. (2011). Preparation of size-controlled bovine serum albumin (BSA) nanoparticles by a modified desolvation method. Food Chem 127:1892–8
   Web of Science ®Google Scholar
• Kakran M, Sahoo NG, Li L, Judeh Z. (2010). Dissolution of artemisinin/polymer composite nanoparticles fabricated by evaporative precipitation of nanosuspension. J Pharm Pharmacol 62:413–21
   PubMed Web of Science ®Google Scholar
• Kannan R, Kuhlenkamp JF, Jeandidier E, et al. (1990). Evidence for carrier-mediated transport of glutathione across the blood--brain barrier in the rat. J Clin Invest 85:2009–13
   PubMed Web of Science ®Google Scholar
• Kannan R, Kuhlenkamp JF, Ookhtens M, Kaplowitz N. (1992). Transport of glutathione at blood -- brain barrier of the rat: inhibition by glutathione analogs and age-dependence. J Pharmacol Exp Ther 263:964–70
   PubMed Web of Science ®Google Scholar
• Kashi TS, Eskandarion S, Esfandyari-Manesh M, et al. (2012). Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method. Int J Nanomedicine 7:221–34
   PubMed Web of Science ®Google Scholar
• Kratzer I, Wernig K, Panzenboeck U, et al. (2007). Apolipoprotein A-I coating of protamine-oligonucleotide nanoparticles increases particle uptake and transcytosis in an in vitro model of the blood--brain barrier. J Control Release 117:301–11
   PubMed Web of Science ®Google Scholar
• Krizbai IA, Deli MA, Pestenacz A, et al. (1998). Expression of glutamate receptors on cultured cerebral endothelial cells. J Neurosci Res 54:814–19
   PubMed Web of Science ®Google Scholar
• Kumari A, Yadav SK, Yadav SC. (2010). Biodegradable polymeric nanoparticles based drug delivery systems. Coll Surf B: Biointerfaces 75:1–18
   PubMed Web of Science ®Google Scholar
• Lalo U, Pankratov Y, Kirchhoff F, et al. (2006). NMDA receptors mediate neuron-to-glia signaling in mouse cortical astrocytes. J Neurosci 26:2673–83
   PubMed Web of Science ®Google Scholar
• Lamprecht A, Ubrich N, Hombreiro Perez M, et al. (2000). Influences of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization technique. Int J Pharm 196:177–82
   PubMed Web of Science ®Google Scholar
• Leung JC, Travis BR, Verlander JW, et al. (2002). Expression and developmental regulation of the NMDA receptor subunits in the kidney and cardiovascular system. Am J Physiol Regul Integr Comp Physiol 283:R964–71
   PubMed Web of Science ®Google Scholar
• Lindqvist A, Rip J, Gaillard PJ, et al. (2012). Enhanced brain delivery of the opioid peptide DAMGO in glutathione PEGylated liposomes: a microdialysis study. Mol Pharm 14:14–24
   Google Scholar
• Liu X, Chen C. (2005). Strategies to optimize brain penetration in drug discovery. Curr Opin Drug Discov Devel 8:505–12
   PubMed Web of Science ®Google Scholar
• Lu W, Zhang Y, Tan YZ, et al. (2005). Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery. J Control Release 107:428–48
   PubMed Web of Science ®Google Scholar
• Mailander V, Landfester K. (2009). Interaction of nanoparticles with cells. Biomacromolecules 10:2379–400
   PubMed Web of Science ®Google Scholar
• Martin HL, Teismann P. (2009). Glutathione – a review on its role and significance in Parkinson's disease. FASEB J 23:3263–72
   PubMed Web of Science ®Google Scholar
• McDannold N, Arvanitis CD, Vykhodtseva N, Livingstone MS. (2012). Temporary disruption of the blood–brain barrier by use of ultrasound and microbubbles: safety and efficacy evaluation in Rhesus Macaques. Cancer Res 72:3652–63
   PubMed Web of Science ®Google Scholar
• Mittnacht U, Hartmann H, Hein S, et al. (2010). Chitosan/siRNA nanoparticles biofunctionalize nerve implants and enable neurite outgrowth. Nano Lett 10:3933–9
   PubMed Web of Science ®Google Scholar
• Muro K, Das S, Raizer JJ. (2006). Convection-enhanced and local delivery of targeted cytotoxins in the treatment of malignant gliomas. Technol Cancer Res Treat 5:201–13
   PubMed Web of Science ®Google Scholar
• Nobs L, Buchegger F, Gurny R, Allemann E. (2003). Surface modification of poly(lactic acid) nanoparticles by covalent attachment of thiol groups by means of three methods. Int J Pharm 250:327–37
   PubMed Web of Science ®Google Scholar
• Pardridge WM. (2005). Drug and gene targeting to the brain via blood–brain barrier receptor-mediated transport systems. Int Congress Series 1277:49–62
   Google Scholar
• Patel P, Acharya S. (2012). Design and development of glutathione conjugated poly(d, l) lactide nanocarriers for delivery of hydrophilic fluorescent marker across blood brain barrier. Curr Nanosci 8:847--57
   Google Scholar
• Patel P, Acharya N, Acharya S. (2011). Potential of surface functionalized nanoparticles for improved therapy of refractory CNS disorders. J Pharmacy Res 4:1093–9
   Google Scholar
• Peltonen L, Aitta J, Hyvonen S, et al. (2004). Improved entrapment efficiency of hydrophilic drug substance during nanoprecipitation of poly(l)lactide nanoparticles. AAPS PharmSciTech 5:115--20
   Web of Science ®Google Scholar
• Rao KS, Reddy MK, Horning JL, Labhasetwar V. (2008). TAT-conjugated nanoparticles for the CNS delivery of anti-HIV drugs. Biomaterials 29:4429–38
   PubMed Web of Science ®Google Scholar
• Reijerkerk A, Kooij G, Van Der Pol SM, et al. (2010). The NR1 subunit of NMDA receptor regulates monocyte transmigration through the brain endothelial cell barrier. J Neurochem 113:447–53
   PubMed Web of Science ®Google Scholar
• Smith QR. (2005). Carrier-mediated transport to enhance drug delivery to brain. Int Congress Series 1277:63–74
   Google Scholar
• Sunitha R, Harika D, Phani A, et al. (2011). A review: nanoparticles as specified carriers in targeted brain drug delivery system. Am J Pharmaceut Technol Res 1:121--34
   Google Scholar
• Uchida T, Yoshida K, Goto S. (1996). Preparation and characterization of polylactic acid microspheres containing water-soluble dyes using a novel w/o/w emulsion solvent evaporation method. J Microencapsul 13:219–28
   PubMed Web of Science ®Google Scholar
• Umnarat S. (2006). Brain delivery enhancement of curcumin via nanotechnology [thesis]. Mahidol University
   Google Scholar
• Wilson B, Samanta MK, Santhi K, et al. (2008). Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease. Brain Res 20:159–68
   Google Scholar
• Witschi C, Doelker E. (1998). Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing. J Control Release 51:327–41
   PubMed Web of Science ®Google Scholar
• Yang R, Yang SG, Shim WS, et al. (2009). Lung-specific delivery of paclitaxel by chitosan-modified PLGA nanoparticles via transient formation of microaggregates. J Pharm Sci 98:970–84
   PubMed Web of Science ®Google Scholar
• Yu MK, Park J, Jon S. (2012). Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy. Theranostics 2:3–44
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huo M, Zhou J, et al. (2010). DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J 12:263–71
   PubMed Web of Science ®Google Scholar
• Zhao D, Zhao X, Zu Y, et al. (2010). Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles. Int J Nanomedicine 5:669–77
   PubMed Web of Science ®Google Scholar
• Zlokovic BV, Mackic JB, McComb JG, et al. (1994). Evidence for transcapillary transport of reduced glutathione in vascular perfused guinea-pig brain. Biochem Biophys Res Commun 201:402–8
   PubMed Web of Science ®Google Scholar